Jeannette Potts
Responsabile della Conformità presso UNIQURE N.V.
Patrimonio netto: 454 504 $ in data 31/05/2024
Posizioni attive di Jeannette Potts
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| FORMA THERAPEUTICS HOLDINGS, INC. | Consigliere Generale | 01/09/2019 | - |
| Segretario Aziendale | 01/09/2019 | - | |
| UNIQURE N.V. | Responsabile della Conformità | - | - |
| Consigliere Generale | - | - |
Storia della carriera di Jeannette Potts
Precedenti posizioni note di Jeannette Potts
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Direttore Tecnico/Scientifico/R&S | 01/03/2013 | 01/08/2019 |
Viroblock SA
 Viroblock SA Miscellaneous Commercial ServicesCommercial Services Viroblock SA develops and commercializes antiviral products. Viroblock technology uses a novel mechanism of action to inactivate enveloped viruses, human and avian such As influenzas, SARS virus and the AIDS virus. The company was founded by Donald F. H. Wallach in 2005 and is headquartered in Irvine, CA. | Vendite & Marketing | - | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Formazione di Jeannette Potts
| Smith College | Undergraduate Degree |
| University of Virginia | Doctorate Degree |
| Suffolk University | Graduate Degree |
| Trinity College Dublin | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Svizzera | 2 |
| Irlanda | 2 |
Posizioni
| General Counsel | 2 |
| Undergraduate Degree | 2 |
| Corporate Secretary | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 5 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| UNIQURE N.V. | Health Technology |
| Aziende private | 4 |
|---|---|
Forma Therapeutics Holdings, Inc.
 Forma Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Forma Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. engages in the research, development and commercialization of novel therapeutics for the treatment of hematologic diseases and cancers. Its product pipeline consists of FT-4202 for the treatment of sickle cell disease and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company was founded by Michael A. Foley in December 2011 and is headquartered in Watertown, MA. | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Viroblock SA
Viroblock SA Miscellaneous Commercial ServicesCommercial Services Viroblock SA develops and commercializes antiviral products. Viroblock technology uses a novel mechanism of action to inactivate enveloped viruses, human and avian such As influenzas, SARS virus and the AIDS virus. The company was founded by Donald F. H. Wallach in 2005 and is headquartered in Irvine, CA. | Commercial Services |
- Borsa valori
- Insiders
- Jeannette Potts
- Esperienza
